Content by German Institute for Quality and Efficiency in Health Care (IQWiG)

|3 min read

Antibody-Drug Conjugate Benefits HER2-Low Breast Cancers

Patients with HER2-low breast cancers were included in the clinical trial proving the efficacy of trastuzumab deruxtecan monotherapy
|2 min read

Single-Arm Trials May Not Be Effective in Drug Development

Experts urge EMA to prioritize evidence-based drug development over accelerated marketing authorization
Page 1 of 1